Calcium's role in alleviating gastritisAlleviation of calcium hydroxide nanoparticles induced genotoxicity and gastritis by coadministration of calcium titanate and yttrium oxide nanoparticles in mice.
Moderate relevance to calcium effects
We observed that various nanoparticles, particularly calcium hydroxide (Ca(OH)), can significantly impact gastritis and DNA integrity in mice. In our study, we administered a dose of 50 mg/kg of Ca(OH) nanoparticles orally three times a week for two weeks. This led to increased DNA damage and reactive oxygen species (ROS) generation, indicating a heightened inflammatory response.
Surprisingly, when we combined Ca(OH) with calcium titanate (CaTiO) and yttrium oxide (YO) nanoparticles, the harmful effects were remarkably reduced. The observed inflammation and DNA damage levels returned to a range similar to the negative control group, demonstrating that CaTiO and YO nanoparticles effectively mitigated the adverse effects induced by Ca(OH).
Importantly, the combination treatment altered the expression levels of key genes involved in inflammation. While Ca(OH) alone raised the levels of inflammatory markers, the coadministration with CaTiO and YO resulted in significant recovery, underscoring a protective effect.
Overall, this suggests a potential pathway for managing inflammation and DNA damage linked to calcium hydroxide exposure. However, we recommend further investigations to explore the full implications of these findings and the toxicological effects of these nanoparticles.
Read More
Zinc Carnosine Enhances EradicationZinc carnosine-based modified bismuth quadruple therapy standard triple therapy for eradication: A randomized controlled study.
Relevant to gastritis treatment
We conducted a study to explore the effectiveness of a modified bismuth quadruple therapy that included zinc carnosine in treating gastritis, compared to the standard triple therapy. Our participant group consisted of 92 patients who showed symptoms of dyspepsia and tested positive on a urea breath test for the infection.
The study was structured with one group receiving the traditional 14-day standard treatment, which included esomeprazole, amoxicillin, and clarithromycin. The other group was treated with a 10-day regimen that added bismuth subcitrate and zinc carnosine to the same foundational therapies. After completing their courses, we retested the patients to assess the success of the eradication therapy.
Our findings revealed that the modified therapy group achieved a significantly higher eradication rate of 93.5% compared to just 69.6% in the standard treatment group. Besides dizziness, the side effects were similar between the two therapies, indicating that the addition of zinc carnosine did not introduce significant new risks.
This research suggests that zinc carnosine can be beneficial in enhancing the effectiveness of treatments for gastritis while maintaining a favorable safety profile. Therefore, those dealing with difficult-to-treat gastritis might find hope in this innovative approach.
Read More
Our examination focuses on the intriguing case of a 33-year-old man diagnosed with Cronkhite-Canada syndrome (CCS), a rare condition affecting the gastrointestinal tract and skin. During his hospital stay, he presented with severe gastrointestinal symptoms alongside notable skin changes.
To address his condition, the treatment regime included high protein supplements, proton pump inhibitors, and zinc-vitamin supplements. Over the course of five months, we observed a complete improvement in his symptoms. While this particular case emphasizes the role of zinc within a comprehensive treatment plan, it’s important to note that zinc was part of a multi-component strategy that makes it difficult to isolate its individual effects on gastritis directly.
Nonetheless, this case illustrates how early diagnosis and a well-structured treatment approach—integrating nutritional support—can lead to significant recovery in rare syndromes like CCS.
Read More
Calcium's role in gastritis therapyA Dual-Biomineralized Yeast Micro-/Nanorobot with Self-Driving Penetration for Gastritis Therapy and Motility Recovery.
Moderate relevance to calcium effects
We explored the potential of calcium treatment for alleviating gastritis through innovative yeast micro-/nanorobots. In this study, a self-driving Cur@CaY-robot was devised using a dual biomineralization process to incorporate calcium carbonate. These robots are designed to navigate the harsh gastric environment, effectively delivering curcumin, a natural anti-inflammatory compound.
What we found particularly interesting is how these robots can penetrate deep into thick gastric mucus. This ability not only improves the concentration of curcumin in gastric wall tissues but also releases calcium cations, which seem to play a dual role in both enhancing drug delivery and aiding the recovery of gastric motility in mice suffering from gastritis.
While leveraging the biocompatibility and biodegradability of the yeast-based robots, our findings suggest that calcium can indeed have a notable effect in the context of gastritis treatment. However, it’s important to note that the interplay between calcium and curcumin might complicate our understanding of their individual impacts on gastritis. The study points to promising avenues for future research, emphasizing the need for deeper exploration into how these elements work together.
Read More
Zinc protects against gastritis damageZinc supplementation alleviates oxidative stress to inhibit chronic gastritis the ROS/NF-κB pathway in a mouse model.
Study highlights zinc's effectiveness
We investigated how zinc supplementation impacts chronic gastritis, particularly in the context of oxidative stress and inflammation. By establishing models of inflammatory injury in C57BL/6 mice, we were able to analyze the effects of zinc on the gastric mucosa, which is crucial for maintaining digestive health.
Our findings revealed that when the mice were exposed to a compound known to induce inflammation, there was a noticeable rise in reactive oxygen species (ROS), signaling an increase in oxidative stress. This stress resulted in an uptick in certain harmful factors related to inflammation and cell death. However, when we introduced zinc as a supplement, it effectively reduced these damaging factors, alleviating inflammation and the resulting cell death in both the mouse stomach and cultured cells.
Overall, our study indicates that zinc supplementation can play a significant role in controlling inflammation and protecting against cellular damage caused by oxidative stress in chronic gastritis. By modulating the ROS/NF-κB signaling pathway, zinc demonstrates potential as a protective agent for gastric health.
Read More